Actively Recruiting

Phase 4
Age: 6Months +
All Genders
NCT07177300

Effectiveness of Nontraditional Hydroxyurea Algorithms: Novel and Clinical Evaluations (ENHANCE)

Led by Children's Hospital Medical Center, Cincinnati · Updated on 2025-09-16

50

Participants Needed

1

Research Sites

206 weeks

Total Duration

On this page

Sponsors

C

Children's Hospital Medical Center, Cincinnati

Lead Sponsor

G

Greater Cincinnati Foundation

Collaborating Sponsor

AI-Summary

What this Trial Is About

The main reason for this research study is to learn more about hydroxyurea and the treatment of sickle cell anemia (SCA). Hydroxyurea is a medication that has been studied for many years and has been shown to provide benefits for people with SCA. In this research study, the investigators hope to learn more about how to improve the dosing and monitoring of hydroxyurea and learn more about the long-term effects of hydroxyurea over time. Hydroxyurea is usually dosed based only on your weight. Our study will use a new way to select a starting dose that is based on how each patient absorbs hydroxyurea.

CONDITIONS

Official Title

Effectiveness of Nontraditional Hydroxyurea Algorithms: Novel and Clinical Evaluations (ENHANCE)

Who Can Participate

Age: 6Months +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of sickle cell anemia (HbSS) or sickle-b20-thalassemia (HbSb20)
  • Age 6 months or older at enrollment
  • Clinical decision by patient, family, and healthcare provider to start hydroxyurea treatment
Not Eligible

You will not qualify if you...

  • Current treatment with regularly scheduled blood transfusions
  • Diagnosis of sickle-hemoglobin C disease (HbSC) or sickle-b2+-thalassemia (HbSb2+)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio, United States, 45229

Actively Recruiting

Loading map...

Research Team

W

Wendi L. Long, Sr. Regulatory Specialist, BS, CCRC

CONTACT

T

Teresa Latham, Research Director, DrPH

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here